Financials

  • Market Capitalization 217.78 M
  • Employee 34
  • Founded 2004
  • CEO Christopher U. Missling Ph.D.
  • Website www.anavex.com
  • Headquarter New York, United States
  • FIGI BBG000C9K8K4
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-16.48
Índice preço/fluxo de caixa
151.51

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
3577
KROS
Keros Therapeutics, Inc. - common stock
11.10 USD-5.93%+0.36%+7.25%-26.49%219.69 M USD
3580
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.35 USD-1.36%0.00%+2.84%-46.49%219.12 M USD
3584
CGEN
Compugen Ltd. - Ordinary Shares
2.30 USD-3.77%-1.71%+13.30%+42.86%217.47 M USD
3589
NBP
NovaBridge Biosciences - American Depositary Shares
1.86 USD-2.11%-7.46%+25.68%-58.76%214.61 M USD

Notícias